A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

The expensive medication does little to prevent hospitalisation or death for people who are vaccinated against the virus, a new Australian analysis of randomised controlled trials has found.

PFE trades above its 50-day average for over a month, signaling bullish momentum despite COVID revenue declines and patent ...

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Pfizer has revealed what it will charge for a five-day course of its oral antiviral Paxlovid for COVID-19 when it starts to see it on the commercial market later this year. The drugmaker has set a ...

More than 5 years after the pandemic's start, COVID remains a public health challenge. From October 2024 to April 2025, the ...